Thursday - December 11, 2025
Syntax Bio Receives Award from Breakthrough T1D to Advance Pancreatic Beta Cell Therapy for Type 1 Diabetes
December 10, 2025
NEW YORK, Dec. 10 -- Breakthrough T1D (formerly JDRF) a non-profit dedicated to funding type 1 diabetes research, posted the following news release:

* * *

Syntax Bio Receives Award from Breakthrough T1D to Advance Pancreatic Beta Cell Therapy for Type 1 Diabetes

*

Funding will accelerate development of manufactured pancreatic beta cells capable of restoring insulin production using Syntax's Cellgorithm(tm) technology

CHICAGO . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products